• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群落失调与心房颤动进展的关联:系统评价。

Association of gut microbiome dysbiosis with the progression of atrial fibrillation: A systematic review.

机构信息

Department of General Surgery, Eash Lancashire NHS Hospital, Burnley, UK.

Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.

出版信息

Ann Noninvasive Electrocardiol. 2023 Jul;28(4):e13059. doi: 10.1111/anec.13059. Epub 2023 Mar 20.

DOI:10.1111/anec.13059
PMID:36940225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10335625/
Abstract

OBJECTIVE

Many clinical and preclinical studies have implicated an association between atrial fibrillation (AF) and its progression to imbalances in the gut microbiome composition. The gut microbiome is a diverse and complex ecosystem containing billions of microorganisms that produce biologically active metabolites influencing the host disease development.

METHODS

For this review, a literature search was conducted using digital databases to systematically identify the studies reporting the association of gut microbiota with AF progression.

RESULTS

In a total of 14 studies, 2479 patients were recruited for the final analysis. More than half (n = 8) of the studies reported alterations in alpha diversity in atrial fibrillation. As for the beta diversity, 10 studies showed significant alterations. Almost all studies that assessed gut microbiota alterations reported major taxa associated with atrial fibrillation. Most studies focused on short-chain fatty acids (SCFAs), whereas three studies evaluated TMAO levels in the blood, which is the breakdown product of dietary l-carnitine, choline, and lecithin. Moreover, an independent cohort study assessed the relationship between phenylacetylglutamine (PAGIn) and AF.

CONCLUSION

Intestinal dysbiosis is a modifiable risk factor that might provide newer treatment strategies for AF prevention. Well-designed research and prospective randomized interventional studies are required to target the gut dysbiotic mechanisms and determine the gut dysbiotic-AF relationship.

摘要

目的

许多临床前和临床研究表明,心房颤动(AF)与其肠道微生物组组成失衡之间存在关联。肠道微生物组是一个多样化且复杂的生态系统,其中包含数十亿种产生影响宿主疾病发展的生物活性代谢物的微生物。

方法

为了进行本次综述,使用数字数据库进行了文献检索,以系统地确定报告肠道微生物群与 AF 进展之间关联的研究。

结果

在总共 14 项研究中,共有 2479 名患者被纳入最终分析。超过一半(n=8)的研究报告了 AF 中 alpha 多样性的改变。至于 beta 多样性,有 10 项研究显示出明显的改变。几乎所有评估肠道微生物群改变的研究都报告了与心房颤动相关的主要分类群。大多数研究集中在短链脂肪酸(SCFAs)上,而三项研究评估了血液中的 TMAO 水平,TMAO 是膳食肉碱、胆碱和卵磷脂的分解产物。此外,一项独立的队列研究评估了苯乙酰谷氨酰胺(PAGIn)与 AF 的关系。

结论

肠道菌群失调是一种可改变的危险因素,可能为 AF 的预防提供新的治疗策略。需要进行精心设计的研究和前瞻性随机干预研究,以针对肠道菌群失调机制,并确定肠道菌群失调与 AF 的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7346/10335625/2ab91ee773fd/ANEC-28-e13059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7346/10335625/113ccb111ee6/ANEC-28-e13059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7346/10335625/2ab91ee773fd/ANEC-28-e13059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7346/10335625/113ccb111ee6/ANEC-28-e13059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7346/10335625/2ab91ee773fd/ANEC-28-e13059-g002.jpg

相似文献

1
Association of gut microbiome dysbiosis with the progression of atrial fibrillation: A systematic review.肠道微生物群落失调与心房颤动进展的关联:系统评价。
Ann Noninvasive Electrocardiol. 2023 Jul;28(4):e13059. doi: 10.1111/anec.13059. Epub 2023 Mar 20.
2
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
3
Systematic screening for the detection of atrial fibrillation.用于检测心房颤动的系统筛查。
Cochrane Database Syst Rev. 2016 Jun 3;2016(6):CD009586. doi: 10.1002/14651858.CD009586.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.“口袋里的药丸”策略与偶发性院内治疗或持续性抗心律失常药物治疗相比,用于阵发性心房颤动的系统评价和成本效益评估。
Health Technol Assess. 2010 Jun;14(31):iii-iv, 1-75. doi: 10.3310/hta14310.
6
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
10
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.

引用本文的文献

1
Inflammatory Bowel Disease and Cardiovascular Disease: An Integrative Review With a Focus on the Gut Microbiome.炎症性肠病与心血管疾病:聚焦肠道微生物群的综合综述
Cureus. 2024 Jul 22;16(7):e65136. doi: 10.7759/cureus.65136. eCollection 2024 Jul.
2
Transcriptomic analysis reveals the potential crosstalk genes and immune relationship between Crohn's disease and atrial fibrillation.转录组分析揭示了克罗恩病与心房颤动之间潜在的相互作用基因及免疫关系。
J Thorac Dis. 2024 Feb 29;16(2):1247-1261. doi: 10.21037/jtd-23-1078. Epub 2024 Feb 22.
3
Putative causal relations among gut flora, serums metabolites and arrhythmia: a Mendelian randomization study.

本文引用的文献

1
Changes of the gut microbiota composition and short chain fatty acid in patients with atrial fibrillation.肠道微生物组成和短链脂肪酸在心房颤动患者中的变化。
PeerJ. 2023 Dec 7;11:e16228. doi: 10.7717/peerj.16228. eCollection 2023.
2
Aggravated Gut Microbiota and Metabolomic Imbalances Are Associated with Hypertension Patients Comorbid with Atrial Fibrillation.肠道微生物群和代谢组失衡加重与高血压合并心房颤动患者相关。
Biomolecules. 2022 Oct 9;12(10):1445. doi: 10.3390/biom12101445.
3
PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury.
肠道菌群、血清代谢物与心律失常之间的假定因果关系:一项孟德尔随机化研究。
BMC Cardiovasc Disord. 2024 Jan 11;24(1):38. doi: 10.1186/s12872-023-03703-z.
PAGln,一种与心房颤动相关的肠道微生物代谢物,可作为心房肌细胞损伤的促进剂。
Biomolecules. 2022 Aug 15;12(8):1120. doi: 10.3390/biom12081120.
4
Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling.共生微生物衍生的短链脂肪酸通过 GPR43/NLRP3 信号减轻心房颤动。
Int J Biol Sci. 2022 Jun 27;18(10):4219-4232. doi: 10.7150/ijbs.70644. eCollection 2022.
5
Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation.房颤患者的肠道微生物群和代谢物及其导管消融后的变化。
Microbiol Spectr. 2022 Apr 27;10(2):e0107721. doi: 10.1128/spectrum.01077-21. Epub 2022 Apr 6.
6
Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.心房心肌病:病理生理学与临床后果。
Cells. 2021 Sep 30;10(10):2605. doi: 10.3390/cells10102605.
7
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.肠道微生物群、菌群失调与心房颤动。致心律失常机制及潜在临床意义。
Cardiovasc Res. 2022 Aug 24;118(11):2415-2427. doi: 10.1093/cvr/cvab292.
8
Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation.肠道中与短链脂肪酸相关的基因合成改变与心房颤动患者相关。
BMC Genomics. 2021 Aug 31;22(1):634. doi: 10.1186/s12864-021-07944-0.
9
Does gut microbiota affect atrial rhythm? Causalities and speculations.肠道微生物群会影响心房节律吗?因果关系和推测。
Eur Heart J. 2021 Sep 14;42(35):3521-3525. doi: 10.1093/eurheartj/ehab467.
10
Gut-microbe derived TMAO and its association with more progressed forms of AF: Results from the AF-RISK study.肠道微生物衍生的氧化三甲胺及其与更严重房颤形式的关联:房颤风险研究结果
Int J Cardiol Heart Vasc. 2021 May 24;34:100798. doi: 10.1016/j.ijcha.2021.100798. eCollection 2021 Jun.